Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruixiang Zhang

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Annals of Palliative Medicine|September 14, 2020
Hand-assisted sputum excretion can effectively reduce postoperative pulmonary complications of esophageal cancerWei Wang, Qi Liu, Yongkui Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 TrialXin Wang, Xiaozheng Kang, Ruixiang Zhang, et al.
Thoracic Cancer|January 8, 2025
Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell CarcinomaYafan Yang, Liyan Xue, Xiankai Chen, et al.
Cancer Biology & Therapy|October 27, 2024
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective studyXin Wang, Guojie Feng, Xiongtao Yang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 12, 2024
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort studyNuo Yu, Xiankai Chen, Jiao Li, et al.
Journal of Thoracic Disease|December 13, 2023
Collaborative multidisciplinary management and expertise of cT2-3 locally advanced operable esophageal squamous cell carcinoma: a report of two casesXuefeng Leng, Daisuke Kurita, Yi Zhu, et al.
The Journal of Clinical Investigation|February 25, 2025
A multicenter prospective clinical trial reveals cell-free DNA methylation markers for early esophageal cancerRuixiang Zhang, Yongzhan Nie, Xiaobing Chen, et al.
Nature Medicine|July 2, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trialJianjun Qin, Liyan Xue, Anlin Hao, et al.
Thoracic Cancer|June 26, 2025
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of ThymomaXunliang Yin, Hongtao Duan, Zhengwei Zhao, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Annals of Palliative Medicine|September 14, 2020
Hand-assisted sputum excretion can effectively reduce postoperative pulmonary complications of esophageal cancerWei Wang, Qi Liu, Yongkui Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 15, 2024
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 TrialXin Wang, Xiaozheng Kang, Ruixiang Zhang, et al.
Thoracic Cancer|January 8, 2025
Lymph Node Metastasis for pN+ Superficial Esophageal Squamous Cell CarcinomaYafan Yang, Liyan Xue, Xiankai Chen, et al.
Cancer Biology & Therapy|October 27, 2024
S-1-based concurrent chemoradiotherapy plus nimotuzumab in patients with locally advanced esophageal squamous cell carcinoma who failed neoadjuvant therapy: a real-world prospective studyXin Wang, Guojie Feng, Xiongtao Yang, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|August 12, 2024
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort studyNuo Yu, Xiankai Chen, Jiao Li, et al.
Journal of Thoracic Disease|December 13, 2023
Collaborative multidisciplinary management and expertise of cT2-3 locally advanced operable esophageal squamous cell carcinoma: a report of two casesXuefeng Leng, Daisuke Kurita, Yi Zhu, et al.
The Journal of Clinical Investigation|February 25, 2025
A multicenter prospective clinical trial reveals cell-free DNA methylation markers for early esophageal cancerRuixiang Zhang, Yongzhan Nie, Xiaobing Chen, et al.
Nature Medicine|July 2, 2024
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trialJianjun Qin, Liyan Xue, Anlin Hao, et al.
Thoracic Cancer|June 26, 2025
Expert Consensus on Subxiphoid and Subcostal Arch Thoracoscopic Resection for the Treatment of ThymomaXunliang Yin, Hongtao Duan, Zhengwei Zhao, et al.
Pageof 9